NCT04937270

Brief Summary

Superficial heat therapy is mainly used to relieve menstrual pain, but it does not penetrate deeper than the skin tissue. In order to penetrate deep into the deep layers and promote tissue relaxation, deep heat therapy can be effective. The treatment time for deep heat treatment is controversial, and there is no study on deep heat treatment using radio frequency for dysmenorrhea. Therefore, in this study, by applying radiofrequency waves at different times to the lower abdomen for patients with primary dysmenorrhea, the pain and changes in the autonomic nervous system were compared with thermotherapy to suggest appropriate therapeutic interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

June 23, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 24, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

March 2, 2022

Status Verified

February 1, 2022

Enrollment Period

4 months

First QC Date

June 9, 2021

Last Update Submit

February 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability

    Autonomic nervous system balance tester (SA3000new, Medicore Co. Korea) was used. The subjects placed electrodes on three areas (left arm, left leg, right leg) while lying down and performed for 3 minutes.

    immediate change after intervention in baseline

Study Arms (4)

High frequency application time is 5 minutes

EXPERIMENTAL

The group which treats for 5 minutes by using the high-frequency therapy device

Device: High frequency therapy (5 minutes)

High frequency application time is 7 minutes

EXPERIMENTAL

The group which treats for 7 minutes by using the high-frequency therapy device

Device: High frequency therapy (7 minutes)

High frequency application time is 9 minutes

EXPERIMENTAL

The group which treats for 9 minutes by using the high-frequency therapy device

Device: High frequency therapy (9 minutes)

Superficial heat therapy

ACTIVE COMPARATOR

Group treated with superficial heat therapy for 20 minutes

Device: Superficial heat therapy

Interventions

The high-frequency therapy device (radio frequency therapy, WINBACK, Villeneuve Loubet France) used in this study was used to treat deep heat for 5 minutes using a 500 kHz resistive electric transfer (RET).

High frequency application time is 5 minutes

The high-frequency therapy device (radio frequency therapy, WINBACK, Villeneuve Loubet France) used in this study was used to treat deep heat for 7 minutes using a 500 kHz resistive electric transfer (RET).

High frequency application time is 7 minutes

The high-frequency therapy device (radio frequency therapy, WINBACK, Villeneuve Loubet France) used in this study was used to treat deep heat for 9 minutes using a 500 kHz resistive electric transfer (RET).

High frequency application time is 9 minutes

In the physical therapy used in this study, it was applied for 20 minutes using conventionally used superficial heat therapy.

Superficial heat therapy

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women between the ages of 18-50
  • Regular menstrual cycle (24-32 days)
  • Those who have had symptoms of primary dysmenorrhea for at least 1 year
  • Those who have lower back pain symptoms related to menstrual pain of 5 or higher on the Visual Analysis Scale (VAS)
  • The body mass index is between 20-30

You may not qualify if:

  • pelvic inflammatory disease
  • uterine fibroids, polycystic ovary syndrome. Those with gynecological findings such as endometriosis
  • Those who have used an intrauterine contraceptive device
  • Those who took birth control pills or nonsteroidal anti-inflammatory drugs at the time of the experiment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The wells neuropain clinic

Seoul, 05557, South Korea

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 24, 2021

Study Start

June 23, 2021

Primary Completion

October 30, 2021

Study Completion

November 30, 2021

Last Updated

March 2, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

Locations